Sarepta Therapeutics Inc (SRPT) — Free Cash Flow Generation Index

Latest as of December 2025: 0.96x

Sarepta Therapeutics Inc (SRPT) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of $125.38 Million represents 1% of operating cash flow ($131.21 Million). See Sarepta Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$125.38 Million
USD

Operating Cash Flow

$131.21 Million
USD

Capital Expenditures

$5.83 Million
USD

Sarepta Therapeutics Inc Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Sarepta Therapeutics Inc across 1 annual periods. Explore Sarepta Therapeutics Inc (SRPT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Sarepta Therapeutics Inc (2020–2020)

Year-by-year Free Cash Flow Generation Index for Sarepta Therapeutics Inc. For the full company profile including market capitalisation, see SRPT market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.24x $25.26 Million $107.47 Million $82.20 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).